Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany—2026 Update
Klinische Empfehlungen für das stationäre Management von Infektionen der unteren Atemwege bei Kindern und Jugendlichen mit schwerer neurologischer Beeinträchtigung in Deutschland – Update 2026
European Journal of Pediatrics · 09.11.2026 · 185 (12)
DOI: 10.1007/s00431-026-07482-5 ↗Auf einen Blick
Aktualisierte Empfehlungen zum stationären Management von LRTI bei Kindern und Jugendlichen mit schwerer neurologischer Beeinträchtigung. Betont werden supportive Therapie, antimikrobielle Stewardship und ein stufenweises, risikostratifiziertes Vorgehen.
Fragestellung
Wie sollen stationäre Infektionen der unteren Atemwege bei Kindern und Jugendlichen mit schwerer neurologischer Beeinträchtigung in Deutschland behandelt werden?
Methode
Expert:innenkonsens und neue Daten; Aktualisierung der klinischen Empfehlungen von 2024 für Deutschland.
Ergebnisse
Empfohlen werden symptomatische Maßnahmen wie Hydrierung, Antipyretika, Sauerstofftherapie, Sekretmanagement sowie respiratorische und Hustenunterstützung. Bei Verdacht auf bakterielle LRTI soll die Antibiotikatherapie nach klinischer Schwere, Vorbefunden und Ansprechen gesteuert werden.
Schlussfolgerung der Autor:innen
Die aktualisierten Empfehlungen bieten einen praxisnahen, multidisziplinären Rahmen für das stationäre Management von LRTI bei Kindern und Jugendlichen mit SNI.
Kernaussagen
- Supportive Therapie steht am Beginn der Behandlung.
- Antibiotika nach Schweregrad, Mikrobiologie und Ansprechen auswählen.
- Neu: Entlassplanung, MRDO-Kolonisation und Prophylaxe stärker berücksichtigt.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Leitlinie in der Zeitschrift European Journal of Pediatrics, online erschienen am 09.11.2026. Verfasst von Maximilian David Mauritz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Palliative Care Center, Children's and Adolescents' Hospital, Datteln, 45711, Germany. Maximilian.Mauritz@uni-wh.de. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Nervous System Diseases, Respiratory Tract Infections. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Children and adolescents with severe neurological impairment (SNI) require specialized care due to their complex medical needs. These patients often experience severe, recurrent lower respiratory tract infections (LRTIs). These infections, of both viral and bacterial etiology, pose a significant risk to these patients, often resulting in respiratory insufficiency and long-term impairments. Based on expert consensus and newly available data, we have updated the previous 2024 clinical recommendations on the management of LRTIs in children and adolescents with SNI in Germany. This update now also addresses multidrug-resistant organism colonization, respiratory support, discharge planning, and prophylactic strategies. The recommendations emphasize comprehensive multidisciplinary care, antimicrobial stewardship, and a stepwise, risk-stratified approach to antibiotic therapy. Initial treatment should involve symptomatic care, including hydration, antipyretics, oxygen therapy, secretion management, and respiratory as well as cough support. In suspected bacterial LRTIs, antibiotic treatment (ABT) should be guided by clinical severity, previous microbiological findings, and treatment response, with an aminopenicillin plus a beta-lactamase inhibitor recommended for community-acquired LRTIs and piperacillin-tazobactam reserved for selected high-risk patients. Ongoing management includes regular reassessment, adjustment of ABT based on pathogen identification, and optimization of supportive care. Conclusion : The updated recommendations provide a practical, multidisciplinary framework for the inpatient management of LRTIs in children and adolescents with SNI, combining optimized supportive care with antimicrobial stewardship and a stepwise, risk-stratified approach to antibiotic treatment. What is Known: • Children and adolescents with severe neurological impairment are particularly affected by severe and recurrent lower respiratory tract infections (LRTI) • The indication and choice of antibiotic therapy for bacterial LRTI is often difficult because there are no evidence-based treatment recommendations for this heterogeneous but vulnerable patient population • The frequent overuse of broad-spectrum or reserve antibiotics in this patient population increases selection pressure for multidrug-resistant pathogens What is New: • Compared with the 2024 recommendations, this update provides more detailed guidance on secretion management and respiratory and cough support, introduces explicit discharge criteria, and expands decision-making for patients colonized with multidrug-resistant organisms. The antibiotic strategy has been further specified regarding broad-spectrum antibiotic therapy, while preventive recommendations have been expanded and updated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Palliative Care Center, Children's and Adolescents' Hospital, Datteln, 45711, Germany. Maximilian.Mauritz@uni-wh.de.
- Department of Children's Pain Therapy and Pediatric Palliative Care, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, 58448, Germany. Maximilian.Mauritz@uni-wh.de.
- Department of Infectious Diseases, Dr von Hauner Children's Hospital, LMU University Hospital, Munich, 80337, Germany.
- Department of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, Essen, 45147, Germany.
- Department of Neonatology, Heidelberg University Children's Hospital, Heidelberg, 69120, Germany.
- Department of General Paediatrics and Adolescent Medicine, Medical Faculty, University Medical Centre, University of Freiburg, Freiburg, 79106, Germany.
Zitieren
APA
Mauritz, M. D., von Both, U., Dohna-Schwake, C., Gille, C., Huebner, J., Hufnagel, M., Liese, J. G., Renk, H., Rudolph, H., Schulze-Sturm, U., Stehling, F., Tenenbaum, T., Zernikow, B., Knuf, M., & Simon, A. (2026). Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany—2026 Update. European Journal of Pediatrics, 185(12). https://doi.org/10.1007/s00431-026-07482-5
Vancouver
Mauritz MD, von Both U, Dohna-Schwake C, Gille C, Huebner J, Hufnagel M, et al. Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany—2026 Update. European Journal of Pediatrics. 2026;185(12). doi:10.1007/s00431-026-07482-5
BibTeX
@article{Mauritz2026,
author = {Mauritz, Maximilian David and von Both, Ulrich and Dohna-Schwake, Christian and Gille, Christian and Huebner, Johannes and Hufnagel, Markus and Liese, Johannes G and Renk, Hanna and Rudolph, Henriette and Schulze-Sturm, Ulf and Stehling, Florian and Tenenbaum, Tobias and Zernikow, Boris and Knuf, Markus and Simon, Arne},
title = {Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany—2026 Update},
journal = {European Journal of Pediatrics},
year = {2026},
volume = {185},
number = {12},
doi = {10.1007/s00431-026-07482-5}
}
EUVIMED